6 days ago
NBTX
AnalystsMichael SchmidtMichael Schmidt's Stock Forecasts
AnalystsMichael Schmidt
Analyst Ranking
Top 2%
#77 out of 5242 analysts
Average Return
+47.53%
Win Rate
62%71 out of 114
Risk vs Reward
Poor
Good
Michael Schmidt's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Nanobiotix SaNBTX | +850.69% | $3.27 | $31.04 | 2025-04-04 - 2026-04-02 | Strong Buy |
Relay Therapeutics IncRLAY | +356.95% | $2.95 | $13.48 | 2025-05-07 - 2026-04-07 | Strong Buy |
Urogen Pharma LtdURGN | +330.31% | $4.19 | $18.03 | 2025-05-23 - 2026-04-07 | Strong Buy |
Mersana Therapeutics IncMRSN | +291.91% | $7.42 | $29.08 | 2025-08-14 - 2026-01-05 | Strong Buy |
Cogent Biosciences IncCOGT | +264.21% | $9.78 | $35.62 | 2025-07-08 - 2026-04-07 | Strong Buy |
Michael Schmidt Analyst Color
Get additional color on Michael Schmidt's coverage of popular stocks
21 days ago
CTMX
23 days ago
ERAS
a month ago
TNGX
a month ago
ONC
3 months ago
RVMD
4 months ago
IMNM
8 months ago
CMPX
10 months ago
ADCT
a year ago
VSTM
a year ago
RVMD
a year ago
EXEL
3 years ago
EXEL
3 years ago
SNDX
3 years ago
ONC
4 years ago
ACET
Michael Schmidt's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Nanobiotix SaNBTX | 4 | Strong Buy | $36.00 | +19.44% | Maintains | 6 days ago |
Zentalis Pharmaceuticals IncZNTL | 4 | Strong Buy | $6.00 | +124.72% | Reiterates | 12 days ago |
Compass Therapeutics IncCMPX | 5 | Strong Buy | $12.00 | +125.99% | Reiterates | 15 days ago |
Cytomx Therapeutics IncCTMX | 3 | Strong Buy | $15.00 | +248.84% | Maintains | 21 days ago |
Monte Rosa Therapeutics IncGLUE | 3 | Strong Buy | $30.00 | +75.23% | Maintains | 21 days ago |
Erasca IncERAS | 2 | Strong Buy | $20.00 | +17.23% | Maintains | 23 days ago |
X4 Pharmaceuticals IncXFOR | 1 | Strong Buy | $12.00 | +221.72% | Initiates Coverage On | a month ago |
Tango Therapeutics IncTNGX | 3 | Strong Buy | $20.00 | +1.01% | Maintains | a month ago |
Beone Medicines LtdONC | 8 | Strong Buy | $410.00 | +34.95% | Maintains | a month ago |
Genmab AGMAB | 2 | Strong Buy | $40.00 | +44.67% | Maintains | a month ago |
Revolution Medicines IncRVMD | 5 | Strong Buy | $160.00 | +66.16% | Maintains | 3 months ago |
Immunome IncIMNM | 4 | Strong Buy | $35.00 | +62.19% | Maintains | 4 months ago |
Foghorn Therapeutics IncFHTX | 1 | Strong Buy | $12.00 | +141.45% | Initiates Coverage On | 5 months ago |
Incyte CorpINCY | 5 | Strong Buy | $125.00 | +33.42% | Upgrades | 5 months ago |
Mersana Therapeutics IncMRSN | 4 | Strong Buy | $30.00 | +3.16% | Maintains | 8 months ago |
Adc Therapeutics SaADCT | 5 | Strong Buy | $10.00 | +168.82% | Reiterates | 8 months ago |
Oric Pharmaceuticals IncORIC | 3 | Strong Buy | $18.00 | +102.93% | Reiterates | 8 months ago |
Arvinas IncARVN | 4 | Strong Buy | $15.00 | +31.93% | Maintains | 8 months ago |
Cogent Biosciences IncCOGT | 1 | Strong Buy | $17.00 | -52.27% | Reiterates | 9 months ago |
Arrivent Biopharma IncAVBP | 2 | Strong Buy | $45.00 | +78.64% | Reiterates | 9 months ago |
Urogen Pharma LtdURGN | 1 | Strong Buy | $15.00 | -16.81% | Maintains | a year ago |
Kymera Therapeutics IncKYMR | 1 | Strong Buy | $52.00 | -38.90% | Reiterates | a year ago |
Springworks Therapeutics IncSWTX | 3 | Hold | $47.00 | +0.02% | Reiterates | a year ago |
Relay Therapeutics IncRLAY | 1 | Strong Buy | $10.00 | -25.82% | Maintains | a year ago |
Syndax Pharmaceuticals IncSNDX | 3 | Strong Buy | $32.00 | +29.87% | Reiterates | a year ago |
Merus NvMRUS | 4 | Strong Buy | $109.00 | N/A | Reiterates | a year ago |
Adaptimmune Therapeutics PLCADAPY | 3 | Strong Buy | $1.75 | N/A | Maintains | a year ago |
Verastem IncVSTM | 2 | Strong Buy | $14.00 | N/A | Maintains | a year ago |
Exelixis IncEXEL | 6 | Strong Buy | $42.00 | N/A | Reiterates | a year ago |
Protara Therapeutics IncTARA | 1 | Strong Buy | $20.00 | N/A | Reiterates | a year ago |
Adicet Bio IncACET | 4 | Strong Buy | $112.00 | N/A | Upgrades | 2 years ago |
Immunocore Holdings PLCIMCR | 2 | Strong Buy | $92.00 | N/A | Reiterates | 2 years ago |
Immunogen IncIMGN | 1 | Hold | $31.00 | N/A | Downgrades | 2 years ago |
Xencor IncXNCR | 2 | Strong Buy | $34.00 | N/A | Maintains | 2 years ago |
Mirati Therapeutics IncMRTX | 4 | Strong Buy | $60.00 | N/A | Maintains | 3 years ago |
Blueprint Medicines CorpBPMC | 1 | Strong Buy | $82.00 | N/A | Maintains | 3 years ago |
Seagen IncSGEN | 3 | Strong Buy | $170.00 | N/A | Reiterates | 3 years ago |
Deciphera Pharmaceuticals IncDCPH | 1 | Strong Buy | $22.00 | N/A | Upgrades | 3 years ago |
Neurogene IncNGNE | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Rubius Therapeutics IncRUBY | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Immuneering CorpIMRX | 1 | Strong Buy | $42.00 | N/A | Initiates Coverage On | 5 years ago |
Rain Oncology IncRAIN2 | 1 | Strong Buy | $26.00 | N/A | Initiates Coverage On | 5 years ago |
Cellectis SaCLLS | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Bolt Biotherapeutics IncBOLT | 1 | Strong Buy | $840.00 | N/A | Initiates Coverage On | 5 years ago |
Immunomedics IncIMMU | 1 | Strong Buy | $39.00 | N/A | Maintains | 6 years ago |
Spectrum Pharmaceuticals IncSPPI | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Forty Seven IncFTSV | 1 | Strong Buy | $48.00 | N/A | Maintains | 6 years ago |
Bluebird Bio IncBLUE | 4 | Hold | N/A | N/A | Downgrades | 7 years ago |
Agios Pharmaceuticals IncAGIO | 3 | Buy | $80.00 | N/A | Upgrades | 7 years ago |
Clovis Oncology IncCLVSQ | 2 | Hold | $30.00 | N/A | Initiates Coverage On | 8 years ago |
Five Prime Therapeutics IncFPRX | 1 | Buy | $24.00 | N/A | Reinstates | 8 years ago |
Array Technologies IncARRY | 1 | Buy | $20.00 | N/A | Maintains | 8 years ago |
Juno Therapeutics IncJUNO | 2 | Hold | $87.00 | N/A | Downgrades | 8 years ago |
Arbutus Biopharma CorpABUS | 1 | Hold | $5.50 | N/A | Maintains | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.